Prime Capital Investment Advisors LLC Sells 330 Shares of Humana Inc. (NYSE:HUM)

Prime Capital Investment Advisors LLC lowered its stake in Humana Inc. (NYSE:HUM) by 27.5% during the third quarter, according to its most recent Form 13F filing with the SEC. The firm owned 872 shares of the insurance provider’s stock after selling 330 shares during the period. Prime Capital Investment Advisors LLC’s holdings in Humana were worth $276,000 as of its most recent filing with the SEC.

A number of other hedge funds also recently modified their holdings of the stock. Pzena Investment Management LLC increased its position in shares of Humana by 538.7% in the second quarter. Pzena Investment Management LLC now owns 2,318,347 shares of the insurance provider’s stock worth $866,250,000 after purchasing an additional 1,955,375 shares during the period. Davis Selected Advisers grew its position in Humana by 16.1% in the second quarter. Davis Selected Advisers now owns 2,311,362 shares of the insurance provider’s stock valued at $863,640,000 after acquiring an additional 321,233 shares during the last quarter. Marshall Wace LLP grew its position in Humana by 118.9% in the second quarter. Marshall Wace LLP now owns 1,425,302 shares of the insurance provider’s stock valued at $532,564,000 after acquiring an additional 774,085 shares during the last quarter. Legal & General Group Plc grew its position in Humana by 2.1% in the second quarter. Legal & General Group Plc now owns 1,183,985 shares of the insurance provider’s stock valued at $442,396,000 after acquiring an additional 24,842 shares during the last quarter. Finally, Dimensional Fund Advisors LP grew its position in Humana by 2.1% in the second quarter. Dimensional Fund Advisors LP now owns 1,018,248 shares of the insurance provider’s stock valued at $380,368,000 after acquiring an additional 20,891 shares during the last quarter. Institutional investors own 92.38% of the company’s stock.

Analysts Set New Price Targets

A number of research firms have issued reports on HUM. TD Cowen lifted their target price on Humana from $261.00 to $268.00 and gave the company a “hold” rating in a research report on Monday, November 4th. Sanford C. Bernstein upgraded Humana from a “market perform” rating to an “outperform” rating and set a $308.00 target price on the stock in a research report on Tuesday, October 8th. Jefferies Financial Group cut Humana from a “buy” rating to a “hold” rating and decreased their target price for the company from $519.00 to $253.00 in a research report on Monday, October 7th. Leerink Partnrs lowered Humana from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, October 2nd. Finally, Truist Financial cut their price target on Humana from $400.00 to $260.00 and set a “hold” rating on the stock in a research note on Friday, October 11th. Twenty investment analysts have rated the stock with a hold rating and six have given a buy rating to the company. According to MarketBeat, Humana presently has an average rating of “Hold” and a consensus price target of $315.86.

Humana Price Performance

Shares of HUM opened at $275.67 on Monday. Humana Inc. has a 52-week low of $213.31 and a 52-week high of $527.18. The company has a debt-to-equity ratio of 0.67, a quick ratio of 1.76 and a current ratio of 1.76. The business’s 50 day moving average price is $281.36 and its two-hundred day moving average price is $331.94. The firm has a market cap of $33.19 billion, a PE ratio of 24.42, a price-to-earnings-growth ratio of 2.17 and a beta of 0.52.

Humana (NYSE:HUM) last issued its quarterly earnings results on Wednesday, October 30th. The insurance provider reported $4.16 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.48 by $0.68. Humana had a return on equity of 13.20% and a net margin of 1.18%. The firm had revenue of $29.30 billion for the quarter, compared to analyst estimates of $28.66 billion. On average, equities analysts anticipate that Humana Inc. will post 15.86 EPS for the current year.

Humana Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, January 31st. Shareholders of record on Tuesday, December 31st will be paid a $0.885 dividend. This represents a $3.54 annualized dividend and a yield of 1.28%. The ex-dividend date of this dividend is Tuesday, December 31st. Humana’s dividend payout ratio (DPR) is presently 31.36%.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.